Balasa Dinverno & Foltz LLC increased its position in shares of Colgate-Palmolive (NYSE:CL) by 26.4% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 7,617 shares of the company’s stock after purchasing an additional 1,592 shares during the quarter. Balasa Dinverno & Foltz LLC’s holdings in Colgate-Palmolive were worth $555,000 as of its most recent filing with the SEC.

Other hedge funds have also recently modified their holdings of the company. Baltimore Washington Financial Advisors Inc. raised its holdings in shares of Colgate-Palmolive by 6.6% in the third quarter. Baltimore Washington Financial Advisors Inc. now owns 75,245 shares of the company’s stock worth $5,482,000 after acquiring an additional 4,675 shares during the last quarter. FormulaFolio Investments LLC acquired a new position in shares of Colgate-Palmolive in the third quarter worth $702,000. Howe & Rusling Inc. raised its holdings in shares of Colgate-Palmolive by 350.6% in the third quarter. Howe & Rusling Inc. now owns 7,628 shares of the company’s stock worth $556,000 after acquiring an additional 5,935 shares during the last quarter. Mutual of America Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 0.7% in the third quarter. Mutual of America Capital Management LLC now owns 108,741 shares of the company’s stock worth $7,922,000 after acquiring an additional 776 shares during the last quarter. Finally, Moloney Securities Asset Management LLC raised its holdings in shares of Colgate-Palmolive by 19.8% in the third quarter. Moloney Securities Asset Management LLC now owns 9,920 shares of the company’s stock worth $723,000 after acquiring an additional 1,639 shares during the last quarter. 72.96% of the stock is owned by hedge funds and other institutional investors.

In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of the business’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total transaction of $660,690.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Victoria L. Dolan sold 10,000 shares of the business’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the sale, the insider now directly owns 60,528 shares of the company’s stock, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. In the last three months, insiders have sold 173,673 shares of company stock valued at $12,629,293. 1.02% of the stock is owned by company insiders.

Shares of Colgate-Palmolive (CL) opened at $73.24 on Friday. Colgate-Palmolive has a 1 year low of $63.43 and a 1 year high of $77.27. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. The stock has a market capitalization of $64,409.02, a PE ratio of 25.56, a price-to-earnings-growth ratio of 3.36 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the previous year, the business earned $0.73 earnings per share. The firm’s quarterly revenue was up 2.8% compared to the same quarter last year. equities research analysts forecast that Colgate-Palmolive will post 2.88 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date of this dividend was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.

A number of equities research analysts have recently commented on CL shares. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price objective for the company in a research report on Monday, September 25th. SunTrust Banks raised Colgate-Palmolive from a “hold” rating to a “buy” rating and lifted their price objective for the company from $65.00 to $85.00 in a research report on Wednesday, October 11th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Royal Bank of Canada reaffirmed a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Finally, Jefferies Group reaffirmed a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Two analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have assigned a buy rating to the company. Colgate-Palmolive currently has an average rating of “Hold” and an average target price of $76.04.

COPYRIGHT VIOLATION NOTICE: “Balasa Dinverno & Foltz LLC Raises Position in Colgate-Palmolive (CL)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/15/balasa-dinverno-foltz-llc-raises-position-in-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related stocks with our FREE daily email newsletter.